2m 2m 2m 2m 2m 2m 2m
MINK THERAP (INKT)
NASDAQ
$10.13+$0.07 (+0.70%)
Price as of Oct 22, 2026 7:30 PM EDT- $54.2MMarket Cap
- -24.41%1-Year Change
- BiotechnologyIndustry
MINK THERAP (INKT)
$10.13+$0.07 (+0.70%)
INKT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.06 | ||
Change | -$0.56 (-5.27%) | ||
Open | $10.65 | ||
High | $10.65 | ||
Low | $10.06 | ||
Previous Close | $10.62 | ||
Volume | 9,826 | ||
30-Day Average Volume | 18,564 | ||
1-Week Change | 1.21% | ||
1-Month Change | -16.93% | ||
1-Year Change | -28.95% | ||
3-Year Change | -2.33% | ||
5-Year Change | -91.64% | ||
Fundamentals | |||
Shares Outstanding | 5.1M | ||
Total Assets | $9.6M | ||
Market Cap | $54.2M | ||
Enterprise Value | $50.4M | ||
Period: QTR TTM FY | |||
Revenue | $72,884.00 | ||
Net Income | -$3.1M | ||
Free Cash Flow | -$2.1M | ||
EBIT | -$3.1M | ||
EBITDA | -$3.1M | ||
Net Working Capital | $1.7M | ||
EPS | -$0.62 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | 691 | ||
P/B | -4 | ||
P/E | -17 | ||
PEG | 2 | ||
Price/Free Cash Flow | -26 | ||
Price/Operating Cash Flow | -26 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 01/28/2025 | ||
Earnings & Revenue